Marcel Botha discusses ways the agency can ensure it gets the most accurate results possible from AI.

TPN-101, a potent nucleoside reverse transcriptase inhibitor that specifically inhibits the LINE-1 reverse transcriptase.

The new doll will include an insulin pump, a glucose monitor, and a dress featuring international symbols for diabetes ...

Varda Space Industries announced its Series C fundraiser for medicine creation in space has reached $187 million. This now ...

Approval was based on results from the Phase IIIb TRAILBLAZER-ALZ 6 trial, which showed that Kisunla achieved comparable ...

One of the major complaints levied against FDA by the current administration is that the approval process is too complicated, takes too long, and needs to be modernized. The new leadership pledged to ...